✦ LIBER ✦

Prognostic factors in metastatic malignant melanoma. The southeastern cancer study group experience

✍ Scribed by Gary A. Presant; Alfred A. Bartolucci

Publisher: John Wiley and Sons
Year: 1982
Tongue: English
Weight: 375 KB
Volume: 49
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(19820515)49:10<2192::aid-cncr2820491035>3.0.co;2-r

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A randomized comparison of cyclophospham

A randomized comparison of cyclophosphamide, DTIC with or without piperazinedione in metastatic malignant melanoma

✍ Cary A. Presant; Alfred A. Bartolucci; Charles Balch; MICHAEL TRONER; MD AND THE 📂 Article 📅 1982 🏛 John Wiley and Sons 🌐 English ⚖ 269 KB 👁 2 views

Pigmentary traits, modalities of sun rea

Pigmentary traits, modalities of sun reaction, history of sunburns, and melanocytic nevi as risk factors for cutaneous malignant melanoma in the Italian population : Results of a collaborative case-control study

✍ Luigi Naldi; G. Lorenzo Imberti; Fabio Parazzini; Silvano Gallus; Carlo La Vecch 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 83 KB 👁 2 views

Prospective randomized reappraisal of 5-

Prospective randomized reappraisal of 5-fluorouracil in metastatic colorectal carcinoma a comparative trial with 6-thioguanine

✍ Cary A. Presant; Alex E. Denes; Charlene Liu; Alfred A. Bartolucci; The Southeas 📂 Article 📅 1984 🏛 John Wiley and Sons 🌐 English ⚖ 488 KB 👁 2 views

In order to redefine the effectiveness of 5-fluorouracil (5-FU) as palliative therapy in patients with metastatic colorectal carcinoma, and to compare the effectiveness of 6-thioguanine (6-TG) with that of 5-FU, we studied 176 patients with metastatic colorectal carcinoma in a randomized prospective